168 related articles for article (PubMed ID: 9692108)
41. Effectiveness of nanoparticle albumin-bound paclitaxel plus carboplatin in non-small lung cancer patients with malignant pleural effusion.
Koyama N; Watanabe Y; Iwai Y; Miwa C; Nagai Y; Aoshiba K; Nakamura H
Neoplasma; 2018; 65(1):132-139. PubMed ID: 29322797
[TBL] [Abstract][Full Text] [Related]
42. Clinical pharmacokinetics of paclitaxel liposome with a new route of administration in human based on the analysis with ultra performance liquid chromatography.
Wang X; Zheng H; Zhu Z; Wei Y; Chen L
J Pharm Sci; 2010 Nov; 99(11):4746-52. PubMed ID: 20845471
[TBL] [Abstract][Full Text] [Related]
43. Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46).
Johnson DH; Paul DM; Hande KR; DeVore R
Semin Oncol; 1996 Dec; 23(6 Suppl 16):42-6. PubMed ID: 9007120
[TBL] [Abstract][Full Text] [Related]
44. Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer.
Kruijtzer CM; Schellens JH; Mezger J; Scheulen ME; Keilholz U; Beijnen JH; Rosing H; Mathôt RA; Marcus S; van Tinteren H; Baas P
J Clin Oncol; 2002 Dec; 20(23):4508-16. PubMed ID: 12454106
[TBL] [Abstract][Full Text] [Related]
45. Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancer.
Langer CJ; Leighton J; McAleer C; Comis R; O'Dwyer P; Ozols R
Semin Oncol; 1995 Jun; 22(3 Suppl 6):64-9. PubMed ID: 7541156
[TBL] [Abstract][Full Text] [Related]
46. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
Hainsworth JD; Greco FA
Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
[TBL] [Abstract][Full Text] [Related]
47. Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients.
Hsu LH; Soong TC; Feng AC; Liu MC
J Thorac Oncol; 2006 Jun; 1(5):460-7. PubMed ID: 17409900
[TBL] [Abstract][Full Text] [Related]
48. Paclitaxel and carboplatin in inoperable non-small cell lung cancer.
Kosmidis P; Mylonakis N; Fountzilas G; Samantas E; Athanasiadis A; Skarlos D
Semin Oncol; 1996 Dec; 23(6 Suppl 16):68-70. PubMed ID: 9007126
[TBL] [Abstract][Full Text] [Related]
49. A phase I/II trial of combination paclitaxel and carboplatin in advanced or metastatic non-small cell lung cancer: preliminary results of an ongoing study.
Natale RB
Semin Oncol; 1995 Dec; 22(6 Suppl 15):34-7. PubMed ID: 8643968
[TBL] [Abstract][Full Text] [Related]
50. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network.
Langer CJ; Millenson M; O'Dwyer P; Kosierowski R; Alexander R; Litwin S; McAleer CA; Bonjo CA; Ozols R
Semin Oncol; 1996 Dec; 23(6 Suppl 16):35-41. PubMed ID: 9007119
[TBL] [Abstract][Full Text] [Related]
51. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
Choy H; Yee L; Cole BF
Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of Viscum album extract (Helixor-M) to treat malignant pleural effusion in patients with lung cancer.
Lee YG; Jung I; Koo DH; Kang DY; Oh TY; Oh S; Lee SS
Support Care Cancer; 2019 May; 27(5):1945-1949. PubMed ID: 30218188
[TBL] [Abstract][Full Text] [Related]
53. Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer.
Natale RB
Semin Oncol; 1996 Oct; 23(5 Suppl 12):2-6. PubMed ID: 8941402
[TBL] [Abstract][Full Text] [Related]
54. Phase II study of weekly paclitaxel in patients with non-small cell lung cancer who have failed previous treatments.
Yasuda K; Igishi T; Kawasaki Y; Kato K; Matsumoto S; Katayama S; Sako T; Shigeoka Y; Suyama H; Sugitani A; Yamamoto M; Hitsuda Y; Shimizu E
Oncology; 2004; 66(5):347-52. PubMed ID: 15331920
[TBL] [Abstract][Full Text] [Related]
55. Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study.
Frasci G; Comella P; Scoppa G; Guida C; Gravina A; Fiore F; Casaretti R; Daponte A; Parziale A; Comella G
J Clin Oncol; 1997 Apr; 15(4):1409-17. PubMed ID: 9193333
[TBL] [Abstract][Full Text] [Related]
56. A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer.
Lee JS; Komaki R; Morice RC; Ro JY; Kalapurakal SK; Schea R; Murphy WK; Shin DM; Fox NT; Walsh GL; Hittelman WN; Hong WK
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):121-9. PubMed ID: 10210551
[TBL] [Abstract][Full Text] [Related]
57. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515.
Yoshida K; Sugiura T; Takifuji N; Kawahara M; Matsui K; Kudoh S; Takada M; Fukuoka M; Ariyoshi Y; Fukuda H; Saijo N
Lung Cancer; 2007 Dec; 58(3):362-8. PubMed ID: 17716779
[TBL] [Abstract][Full Text] [Related]
58. Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.
Akerley W; Herndon JE; Egorin MJ; Lyss AP; Kindler HL; Savarese DM; Sherman CA; Rosen DM; Hollis D; Ratain MJ; Green MR
Cancer; 2003 May; 97(10):2480-6. PubMed ID: 12733147
[TBL] [Abstract][Full Text] [Related]
59. Intrapleural doxycycline control of malignant pleural effusions.
Robinson LA; Fleming WH; Galbraith TA
Ann Thorac Surg; 1993 May; 55(5):1115-21; discussion 1121-2. PubMed ID: 8494419
[TBL] [Abstract][Full Text] [Related]
60. A phase I/II study of paclitaxel (TAXOL) and concurrent radiotherapy in advanced nonsmall cell lung cancer.
Kirkbride P; Gelmon K; Eisenhauer E; Fisher B; Dulude H
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1107-11. PubMed ID: 9392551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
